Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
169.6 INR | +2.02% | +2.76% | +5.25% |
28/05 | Marksans Pharma Gets Marketing Approval for Levetiracetam Relonchem in UK | MT |
18/04 | Marksans Pharma's Goa Facility Gets Five Inspectional Observations from US FDA | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.25% | 91Cr | |
+39.16% | 73TCr | |
+30.57% | 59TCr | |
-7.95% | 35TCr | |
+15.49% | 32TCr | |
-0.68% | 27TCr | |
+12.55% | 24TCr | |
+6.65% | 20TCr | |
-6.09% | 20TCr | |
-3.21% | 16TCr |
- Stock Market
- Equities
- MARKSANS Stock
- News Marksans Pharma Limited
- Transcript : Marksans Pharma Limited, Q1 2023 Earnings Call, Aug 16, 2022